Fleury H - Search Results

1

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen.

Le Moing V, Thiébaut R, Chêne G, Leport C, Cailleton V, Michelet C, Fleury H, Herson S, Raffi F; APROCO Study Group. Le Moing V, et al. Among authors: fleury h. J Infect Dis. 2002 Feb 15;185(4):471-80. doi: 10.1086/338929. Epub 2002 Jan 31. J Infect Dis. 2002. PMID: 11865399

2

Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.

Masquelier B, Pereira E, Peytavin G, Descamps D, Reynes J, Verdon R, Fleury H, Garraffo R, Chêne G, Raffi F, Brun-Vézinet F; APROCO/COPILOTE Study Group. Masquelier B, et al. Among authors: fleury h. J Clin Virol. 2005 May;33(1):75-8. doi: 10.1016/j.jcv.2004.11.012. J Clin Virol. 2005. PMID: 15797369 Clinical Trial.

3

Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.

Pellegrin I, Thiébaut R, Blanco P, Viallard JF, Schrive MH, Merel P, Chêne G, Fleury H, Moreau JF, Pellegrin JL. Pellegrin I, et al. Among authors: fleury h. J Med Virol. 2005 Oct;77(2):164-72. doi: 10.1002/jmv.20452. J Med Virol. 2005. PMID: 16121362

4

Immunological markers after long-term treatment interruption in chronically HIV-1 infected patients with CD4 cell count above 400 x 10(6) cells/l.

Thiébaut R, Pellegrin I, Chêne G, Viallard JF, Fleury H, Moreau JF, Pellegrin JL, Blanco P. Thiébaut R, et al. Among authors: fleury h. AIDS. 2005 Jan 3;19(1):53-61. doi: 10.1097/00002030-200501030-00006. AIDS. 2005. PMID: 15627033 Free article.

5

Progression to AIDS or death as endpoints in HIV clinical trials.

Raffi F, Chêne G, Lassalle R, May T, Billaud E, Fleury H, Dellamonica P, Leport C; APROCO Study Group. Anti-protease cohort. Raffi F, et al. Among authors: fleury h. HIV Clin Trials. 2001 Jul-Aug;2(4):330-5. doi: 10.1310/Q2L2-QVRK-4E01-C8F8. HIV Clin Trials. 2001. PMID: 11590536

6

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.

HIV-CAUSAL Collaboration; Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA. HIV-CAUSAL Collaboration, et al. Clin Infect Dis. 2015 Apr 15;60(8):1262-8. doi: 10.1093/cid/ciu1167. Epub 2015 Jan 6. Clin Infect Dis. 2015. PMID: 25567330 Free PMC article.

7

AIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000-2008: hospital-based cohort studies.

Luz PM, Bruyand M, Ribeiro S, Bonnet F, Moreira RI, Hessamfar M, Campos DP, Greib C, Cazanave C, Veloso VG, Dabis F, Grinsztejn B, Chêne G; IPEC/FIOCRUZ Cohort and the Aquitaine ANRS C03 Study Group. Luz PM, et al. BMC Infect Dis. 2014 May 21;14:278. doi: 10.1186/1471-2334-14-278. BMC Infect Dis. 2014. PMID: 24885790 Free PMC article.

8

Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA.

Masquelier B, Neau D, Chêne G, Larbère J, Birac V, Ragnaud JM, Fleury HJ. Masquelier B, et al. Among authors: fleury hj. J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):309-12. doi: 10.1097/00126334-200112010-00001. J Acquir Immune Defic Syndr. 2001. PMID: 11707665 Clinical Trial.

9

Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.

Peuchant O, Thiébaut R, Capdepont S, Lavignolle-Aurillac V, Neau D, Morlat P, Dabis F, Fleury H, Masquelier B; ANRS CO3 Aquitaine Cohort. Peuchant O, et al. Among authors: fleury h. AIDS. 2008 Jul 31;22(12):1417-23. doi: 10.1097/QAD.0b013e3283034953. AIDS. 2008. PMID: 18614864 Free article.

10

Severe morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine Cohort.

Hessamfar M, Colin C, Bruyand M, Decoin M, Bonnet F, Mercié P, Neau D, Cazanave C, Pellegrin JL, Dabis F, Morlat P, Chêne G; GECSA study group. Hessamfar M, et al. PLoS One. 2014 Jul 30;9(7):e102671. doi: 10.1371/journal.pone.0102671. eCollection 2014. PLoS One. 2014. PMID: 25076050 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters